 Connection
Kristen Nadeau to Cross-Over Studies
This is a "connection" page, showing publications Kristen Nadeau has written about Cross-Over Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.938 |
|
|
|
-
Simon SL, Snell-Bergeon JK, Schäfer M, Barker AJ, Browne LP, Truong U, Tell SS, Vigers T, Baumgartner AD, Lyon E, Polsky S, Schauer IE, Nadeau KJ. Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR-T1D study. Diabetes Obes Metab. 2024 07; 26(7):2662-2672.
Score: 0.695
-
Tell SS, Schafer M, Vigers T, Baumgartner AD, Lyon E, Gross S, Polsky S, Snell-Bergeon JK, Schauer IE, Nadeau KJ. Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo-controlled crossover study. Diabetes Obes Metab. 2022 11; 24(11):2148-2158.
Score: 0.154
-
Davidson JA, Creasy SA, Meneses E, Brinton JT, Bernard A, Bowen AE, Hawkins SMM, Cree MG, Nadeau KJ, Melanson EL, Wright KP, Simon SL. The effect of an experimental sleep extension manipulation on timing and duration of sedentary behavior and physical activity in habitually short-sleeping and inactive adolescents: Results from a randomized crossover trial. Sleep Health. 2026 Jun; 12(3):400-406.
Score: 0.050
-
Schäfer M, Browne LP, Truong U, Bjornstad P, Tell S, Snell-Bergeon J, Baumgartner A, Hunter KS, Reusch JEB, Barker AJ, Nadeau KJ, Schauer IE. Bromocriptine Improves Central Aortic Stiffness in Adolescents With Type 1 Diabetes: Arterial Health Results From the BCQR-T1D Study. Hypertension. 2023 02; 80(2):482-491.
Score: 0.040
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|